BioHarvest Sciences Operating Income 2020-2024 | BHST

BioHarvest Sciences operating income from 2020 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
BioHarvest Sciences Annual Operating Income
(Millions of US $)
2023 $-10
2022 $-11
2021 $-8
2020 $-6
2019 $-2
2019 $-4
2018 $-4
BioHarvest Sciences Quarterly Operating Income
(Millions of US $)
2024-06-30 $-2
2024-03-31 $-1
2023-12-31 $-3
2023-09-30 $-2
2023-06-30 $-3
2023-03-31 $-3
2022-12-31 $-3
2022-09-30 $-3
2022-06-30 $-2
2022-03-31 $-3
2021-12-31 $-1
2021-09-30 $-3
2021-06-30 $-2
2021-03-31 $-2
2020-12-31 $-2
2020-09-30 $-2
2020-06-30 $-1
2020-03-31 $-1
2019-12-31
2019-09-30 $-1
2019-06-30 $-0
2019-03-31
Sector Industry Market Cap Revenue
Medical MED-BIOMED/GENE $0.098B $0.013B
BioHarvest Sciences Inc. is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications. BioHarvest Sciences Inc. is based in Vancouver, Canada.
Stock Name Country Market Cap PE Ratio
Primo Water (PRMB) United States $4.535B 35.81
P.A.M Transportation Services (PAMT) United States $0.430B 0.00
Rigetti Computing (RGTI) United States $0.325B 0.00
Alpha Cognition (ACOG) Canada $0.035B 0.00
Atlantic Coastal Acquisition II (ABP) United States $0.000B 0.00